Laurent Meijer

22PUBLICATIONS
50CO-AUTHORS
NanomaterialsCharacterisation of biological macromoleculesMolecular targetsDevelopmental genetics (incl. sex determination)Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|May 14, 2026
Nitrogen-Doped Graphene Quantum Dots Conjugated to Leucettinib-21 Rescue Differentiating Zebrafish Purkinje Cells by Inhibiting Dyrk1A Kinase.

|May 14, 2026
Mapping the Brain Interaction Network of the Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Targeted by Leucettinib-21 Using Affinity Chromatography.

|Feb 12, 2026
Leucettinib-21 decreases dosage effects of DYRK1A in human trisomy 21 iPSC-derived neural cells.

Nicole R West, Mattias F Lindberg, Julien Dairou

|Sep 03, 2025
Network Modeling Predicts How DYRK1A Inhibition Promotes Cardiomyocyte Cycling after Ischemic/Reperfusion Injury.

Bryce C Murillo, Alexander Young, Kaitlyn L Wintruba

|Jan 24, 2024
Increased dosage of DYRK1A leads to congenital heart defects in a mouse model of Down syndrome.

Eva Lana-Elola, Rifdat Aoidi, Miriam Llorian

|Dec 05, 2023
Chemical, Biochemical, Cellular, and Physiological Characterization of Leucettinib-21, a Down Syndrome and Alzheimer's Disease Drug Candidate.

Mattias F Lindberg, Emmanuel Deau, Frédéric Miege

Pageof 4

Frequent Collaborators

5 joint publications

Mattias F Lindberg

3 joint publications

Stefan Knapp

2 joint publications

Conrad Kunick

2 joint publications

Yann Herault